DEF 14A

Company

Protalix BioTherapeutics, Inc.

Filed

March 16, 2017

Period of Report

April 12, 2017

Accession Number

0001144204-17-015102

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →